Relafen 750, or Relafen, or Naproxcinod, or the medication represents a targeted approach within pain control, viewed from a biochemical pharmacy perspective. The formulation, comprising naproxcinod, is designed to modulate cyclooxygenase (COX) activity, particularly COX-2, while demonstrating re